Advertisement

Latest Articles in pharma

Glenmark Acquires Development, Commercial Rights For Novel Cancer Molecule From US Firm

Glenmark Pharmaceuticals entered into a licensing agreement with the Boston-based APC Therapeutics Inc, a biopharmaceutical research firm focused on building a portfolio of immuno-oncology therapies, acquiring rights of a potential cancer drug molecule that is currently under development

Read More

Millions Of Employees In Healthcare Sector Are At Risk Of Losing Jobs

With price control over cardiac stents and generic prescription proposal, medical device makers and pharmaceutical giants are expected to hand over pink slips to their employees

Read More

Goverment Extends Price Control Over Commonly Used Vaccinations And Medicines

Drug price watchdog, National Pharmaceutical Pricing Authority (NPPA) has fixed or revised retail prices of 37 scheduled formulations

Read More

Dr Reddy's Sees No Impact From Pricing Regulator Notice

Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval.

Read More

Merck Opens New M Lab Collaboration Centre In Bengaluru

The new M Lab Collaboration Centre in Bengaluru is one of the company’s 9 such centers around the world

Read More

Prices Of Permanent Hearing Solutions Slashed By Over 40% In Last 10-year

Discovering your child is deaf or has hearing loss can be painful. But the only good news is the shrinking cost of cochlear implants, an electronic medical device which could be a lifetime cure for deafness

Read More

‘OTC Allows Us To Keep In Touch With What Indian Consumers Want’

Nandini Piramal, Executive Director, Piramal Enterprises Ltd. leads from the front

Read More

Aurobindo Pharma Eyes US Plant Amid Donald Trump Push On Jobs

Drugmaker Aurobindo Pharma said on Friday it was looking to set up a manufacturing facility for injectable products in the United States, days after President Donald Trump called on pharmaceutical companies to make more drugs locally

Read More

Trump Presidency Impact | A Sickly Outlook

Trump’s interventionist approach can negatively impact the Indian pharma industry, which is heavily dependent on the US market

Read More

Budget 2017 | Amendment In D&C Act To Disrupt Pharma Marketing

The Union Budget-2017 proposal to drastically amend the Drugs and Cosmetics Act to enable availability and affordability of cheaper generic drugs to patients is expected to have key impacts on the local drug industry

Read More

Pharma Industry Wants Budget To Offer Tax Clarity

The pharmaceutical industry has asked the government to bring in more clarity in terms of tax structure and provide incentives on research and development as part of its budget wish-list

Read More

Collaboration Can Lead Us To Better Discovery

Drug discovery has changed. The model of big pharma retaining all the knowledge within has become obsolete

Read More

Sun Pharma Buys Novartis’ Anti-cancer Brand Odomzo For $175 Million

Reason for selling this new anti-cancer drug by Novartis, which consolidated its global oncology business by acquiring the entire cancer drug portfolio of GlaxoSmithKline (GSK) in a $16 billion global deal in March 2015, is not disclosed

Read More